Advertisement
UK markets closed
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     
  • AIM

    789.87
    +6.17 (+0.79%)
     
  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    48,513.77
    -1,700.21 (-3.39%)
     
  • CMC Crypto 200

    1,261.13
    -96.88 (-7.13%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     

Germany does U-turn on AstraZeneca jab and approves its use for people aged 65 and over

 (Getty Images)
(Getty Images)

Germany has approved giving the AstraZeneca Covid-19 vaccine to people aged 65 and over.

Health minister Jens Spahn said the country's independent vaccine committee had made the decision, hailing it "good news for older people who are waiting for a vaccination”.

“They will get vaccinated faster,” he added.

The vaccine made by British-Swedish company and developed by Oxford University is one of three authorised for use in the 27-nation European Union.

But several countries, including Germany, initially restricted it to people aged under 65, or in some cases under 55, citing a lack of data on its effectiveness in older people.

ADVERTISEMENT

The policy has led to a low take-up of available doses, slowing vaccination efforts. In Germany two-thirds of 1.4 million delivered doses remained in storage on Monday.

Read More

U-turn: Germany and France set to give Oxford jab to over 65s

BitCoin blackmailer who threatened to blow up NHS hospital sentenced

Angela Merkel refuses AstraZeneca vaccine as 1.4m doses go unused